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SUMMARY 
A novel plasmid vector that is able to replicate both in Escherichia coil and in Streptococcus sanguis is 
described. This 9.2-kb plasmid, designated pVA856, carries Cm r, Tc r and Em r determinants that are expressed 
in E. coli. Only the Em r determinant is expressed in S. sanguis. Both the Cm r and the Tc' of pVA856 may be 
insertionally inactivated. This plasmid affords several different cleavage-ligation strategies for cloning in E. coli 
followed by subsequent introduction of chimeras into S. sanguis. In addition, we have modified a previously 
described E. coli-S, sanguis shuttle plasmid [pVA838; Macrina et al., Gene 19 (1982) 345-353], so that it is 
unable to replicate in S. sanguis. The utility of such a plasmid for cloning and selecting sequences enabling 
autonomous replication in S. sanguis is demonstrated. 
INTRODUCTION 
The principal strategies for implementing mole- 
cular cloning in naturally transformable strepto- 
coccal hosts have been recently reviewed (Macrina 
* To whom correspondence and reprint requests should be sent 
at Box 678, MCV Station, Richmond, VA 23298 (U.S.A.). 
Abbreviations: Cm f, chioramphenicol resistance; Cm s, chlor- 
amphenicol sensitivity; Emq erythroraycin resistance; Em s, 
erythromycin sensitivity; kb, kilobase pairs; Tc r, tetracycline 
resistance; TcL tetracycline sensitivity; ::, novel joint, [ ], 
indicates plasmid-carrier state. 
et al., 1982a,b). Using suitable vectors (Macrina, 
1980a), plasmid-d~rived sequences may be readily 
cloned by standard methods. However, the cloning 
of host chromosomal fragments has been proble- 
matic owing to the requirements placed on plasmids 
entering genetically competent, transformable strep- 
tococci. Because plasmid transformation requires 
two-hit kinetics with monomers, or the entrance of 
oligomeric forms, the probability of generating spe- 
cific transformants from a ligation mixture of chro- 
mosomal fragments and vector is extremely low 
(Macrina et at., 1981 ; 1982a,b; Saunders and Guild, 
1981). The net effect of such cloning has been to yield 
0378-1119/83/$03.00 © 1983 Elsevier Science Publishers 
146 
recombinant molecules of limited value due to the 
presence of extensive deletions. 
One strategy that has been employed successfully 
to circumvent this problem is to use a marker-rescue 
system called "helper-plasmid cloning" by Gryczan 
et al. (1980). We have employed this method to clone 
a chromosomal tetracycline-resistance determinant 
from S. mutans in S. sangu/s (Tobian and Macrina, 
1982). Belmke (1982) has also described a similar 
streptococcal marker rescue system. As an alterna- 
tive to "'heiper-plasmid cloning", the construction 
and use of an Escherichia-Streptococcus shuttle 
plasmid vector recently has been reported (Macrina 
et al., 1982c). 
In this communication, we describe the construc- 
tion of a new, useful shuttle vector that affords a 
variety of cloning strategies, including two modes of 
insertional inactivation. In addition, a novel vector 
that allows the cloning of streptococcal replication 
origins has been derived from the previously reported 
shuttle vector, pVA838 (Macrina et al., 1982c). 
EXPERIMENTAL 
Two bacterial strains were used h~ this work. 
E. coli DI~ 1 I, kindly suppSed by Dr. Julian Da~e~ 
has been described previously (Macrina et.,d., 
1982c). Its principal features are hypersensitivity to 
antibiotics (including macrofdes, fusidic acid and 
puromycin) and restriction deficiency. S. sanguis 
V288 is our laboratory designation for the Challis 
strain, which is naturally transformable. Media, drug 
concentrations, plasmid isolation, restriction endo- 
nuclease site mapping, copy number determination, 
plasmid segregation studies, cloning methods and 
transformation protocols were as pre~ously publish- 
ed (Macrina et al., 1982c). Streptococcal transfor- 
mation frequency was expressed as transformants 
per ~g DNA per viable recipient at the time of DNA 
addition. 
The previously reported Escherichia'Strept°c°ccus 
shuttle vehicle pVA838, was constructed by the in 
vitro ligation of H/ndHI~leaved pACYC 184 (Chang 
and Cohen, 1978)and HindIII-cleaved pVA749 
(Macrina et al., 1982a). pVA838 is 9.2 kb in size and 
confers Em r and C m  r in E.  coli, while only the E m '  
determinant is expressed in S. sanguis. As a cloning 
vehicle in E. coil, the Cm r determinant can be 
inactivated by the insertion of fragments into its 
EcoRI or Pmll sites. Five additional enzyme sites 
(BamHI, Sph I, Sail, Nrul, Xbal) are also available 
for cloning into pVA838 but these do not inactivate 
either drug resistance determinant. 
We since have constructed a novel shuttle 
replicon, designated pVA856, consisting of 
pACYCI84 and pVA749 linked together at their 
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Fig. !. Plasmid restriction maps. Coordinates (kb) are on the 
inside of each circular map. The approximate location ofthe Em', 
Cm" and Tc" determinants are indicated. The segments of 
pVA838 and pVA856 corresponding to pVA749 and pACYC184 
are indicated by thick and thin lines, respectively. Plasmids 
pVA856 and pVA838 may be propagated in either E. coil or 
S. sanguis. Plasmid pACYCi84 replicates in E. coil but not in 
S. sanguis. Plasmid pVA749 replicates in S. sanguis but not in 
E. coll. 
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unique Aval sites. A restriction et~donuclease site 
map of pVA856 and each of its component replicons 
is shown in Fig. 1. For comparative purposes a map 
ofpVA838 is also illustrated. In contrast to pVA838, 
all of the resistance determina~-tts of the parental 
replicons are pr,,,served in pVA856. Hence, passenger 
DNA may be cloned into pVA856 at the BamHl,  
Sphl,  Sai l  or Nrul sites (see Macrina et al., 1982c) 
and inserts monitored via the inactivation of Tc r. In 
addition, inserts into pVA856, employing the EcoRl 
or P m l l  (fragment replacement) sites, can be 
detected by Cm r inactivation. 
Although the pVA856 shuttle vector provides 
more versatility in terms of insertion possibilities, it 
does present a disadvantage as compared to 
pVA838. Continued passage of E. coli[pVA856] 
under nonselective conditions resulted in the exten- 
sive loss of all plasmid markers indicating plasmid 
segregation (Table I). This was verified by the exami- 
nation of numerous cell lysates prepared from drug- 
sensitive segregants (not shown). Some instability of 
pVA856 also was noted in S. sanguis grown non- 
selectively (Table I). In contrast, pVA838 was rela- 
tively stably inherited in nonselectivdy grown cells. 
The instability of pVA856 in E. coli may be due to 
the fact that some pACYC 184 replication machinery 
is near theAval  site (see Meacock and Cohen, 1980). 
Its instability in S. sanguis remains unexplained 
because we have demonstrated that the A val site on 
t 
pVA749 lies in a dispensible area (Macrina et al., 
1982a). In any event, growth of pVA856-containing 
cells in the presence of one or more of the appropriate 
antibiotics eliminates the problems associated with 
plasmid segregation, pVA856, like pVA838, may be 
amplified, albeit modestly in E. coli but not in 
S. sanguis (Table I; see Macrina et al., 1982c). 
Plasmid pVA856 is being successfully used by us 
and others to clone both plasmid and chromosomal 
sequences of streptococcal origin in E. coli. Once 
constructed, these molecules may be transformation- 
ally introduced into S. sanguis as purified monomeric 
and/or oligomeric chimeras, greatly reducing the risk 
of deletion formation of cloned sequences (see 
Macrina et al., 1982b). 
The restriction endonuclease cleavage map of 
pVA838 (see Fig. 1) enabled us to predict that a 
derivative of this plasmid missing the C!aI-B 
(approx. 4.3 to 7.8 kb) and ClaI-C (approx. 4.0 to 
TABLE 1 
Copy number and plasmid stability 
Plasmid Host Plasmid copies/ 
Chromosome equivalent ~ 
Frequency of 
plasmid marker loss ~ 
Unamplified Amplified b at 37-" C at 42-- C 
(%) (%) 
pVA856 E. coil ! 3 33 98 N.D. 
pVA856 S. sanguis 14 N.D. d 22 N.D. 
pVA838 E. coil 12 35 9 N.D. 
pVA838 S. sanguis 13 N.D. < i N.D. 
pVA891 E. coil 15 36 19 N.D. 
pVAI S. sanguis 12 N.D. 6 85 
pVA961 S. sanguis 12 N.D. 18 74 
a Chromosome sizes were taken as 2.5 x 109 Dal for E. coli (Cooper and Heimstetter, 1968) and 1.8 x 109 Dal for S. sanguis (Macrina 
et al., 1977). Results are presented as the average of at least three experiments. Plasmid copy number was determined by measuring 
and comparing radiolabelled plasmid and chromosomal DNA recovered from agarose gels, exactly as described in Macrina et al. 
(1980b). 
b Mid-log phase cells were treated with 300/~g/ml spectinomycin for 6 h prior to preparation of crude cell lysates. The relatively modest 
amplification (2-3-fold) of the shuttle vectors compared to pACYC184 (15-fold; M acrina et al., 1982c) remains unexplained. 
c Plasmid marker segregation was performed as described by Macrina et al. (1980a). Several colonies, picked from solid selective 
medium, were grown overnight at 37°C in drug-free broth. A sample of this culture was diluted 1:10000 in fresh, drug-free broth and 
grown to stationary phase at 37°C. Cells ~'rom this culture then were grown as single colonies on solid, drug-free medium and scored 
for resistance phenotypes by replica plating. Results are presented as the average of several experiments. 
d Not done. 
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4.3 kb) fragments would replicate in E. coli and still 
reta in Cm' and Em'. Accordingly, about 0.3 Atg of 
pVA838 was cleaved with Clal, figated and trans- 
formed into E. coli DB l I selecting for Cm" and EmL 
Transformants were recovered mid the majority of 
those examined contained a 5.4-kb plasmid. The 
Cm' and Em" levels in these transformants were 
indistinguishable from E. cohtpVA838] (growth on 
25/~g/ml and l0 pg/mi of drug, respectively). 
One such transformant was selected for further 
study. Its plasmid, designated pVA891, was purified 
and a restriction endonuclease cleavage map was 
determined (Fig. 2). Comparison with Fig. l con- 
firms that pVA891 represents a self-ligated Clal-A 
fragment of pVA838. Copy number determinations 
and amplification properties ofpVA891 were similar 
to pVA838, however, the former plasmid was some- 
what less stable in E. coli as compared to its parental 
replicon (Table I). 
The 1.5-kb streptococcal sequence left on pVA891 
(shown as the thick line in Fig. 2) contains the Em ~ 
determinant. None of the streptococcal plasmid 
replication machinery remains (see Macrina et al., 
1982a). Consistent with this observation, pVA891 
failed to yield Em r transformants when it was added 
to genetically competent S. sanguis cells. None of the 
unique cleavage sites on pVA891 (Fig. 2) occur 
within the Em r gene; hence DNA fragments that 
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Fig. 2. Restriction map ofpVA891. This I:lasmid was derived by 
the in vitro removal of the Cial-B and ClaI-C fragments of 
pVA838 (see Fig. I). 
cloned into this plasmid using any of the ten restric- 
tion sites shown in Fig. 2. 
To test the utility of pVA891 we mixed ( I : I )  and 
ligated EcoRl-cleaved pVAI with EcoRl-cleaved 
pVA891 (approx. 0.3/ig of each plasmid), pVAI (a 
deletion derivative of the conjugative pAM/~I 
plasmid) is a 10.4-kb streptococcal plasmid bearing 
an Em ~ gene (Macrina et al., 1980b). Its replication 
in S. sanguis is thermosensitive. It is cleaved by 
EcoRl at two sites yielding 5.3- and 5. l-kb fragments 
(A and B, respectively). The ligation mixture was 
used to transform S. sanguis with selection for Em r. 
Transformants were recovered at a frequency of 
about 9 x I0-  5 and about one-third of the transfor- 
mants contained a plasmid that was slightly larger in 
size than pVAI. One such representative plasmid 
(designated pVA96 I) was examined by a number of 
A B C D E F 
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Fig. 3. Restriction analysis of vector and recombinant plasmids. 
Fragment sizes were determine~ by comparison with the migra- 
tion of Hindlll-cleaved phage R DNA. Lanes: A, pVA891 (see 
Fig. I) cleaved with EcoRl; B, pVAI (Macrina et al., 1980b) 
cleaved with EcoRl showing fragments of 5.3 (A fragment) and 
5.1 kb (B fragment); C, pVA961 cleaved with EcoRl showing 
fragments corresponding to the 5.4-kb pVA891 component 
(upper component) and the 5.l-kb EcoRI.P, pVAI component; 
D, pVA891 cleaved with EcoR! and Hindill; E, pVAI cleaved 
with EcoR! and HindllI. The smallest Hindlll-EcoRi fragment 
is barely visible and its position has been indicated with an 
arrow; F, pVA961 cleaved with EcoR! and Hindlll. The upper 
two components correspond to the Hindlli-EcoR! fragments of 
pVA891 (see lane D) while the lower four components cor- 
respond to four of the fragments liberated by Hindlll and EcoRl 
digestion ofpVAI (see lane E). These four fragments are known 
to comprise the EcoRI-B fragment of pVAi (see Macrina et al., 
1980b). 
criteria and found to be a pVAI-EcoRI-B: :pVA891 
recombinant. Restriction endonuclease analysis of 
pVA961 revealed two EcoRl fragments (Fig. 3, lane 
C). The larger fragment corresponded to EcoRl- 
linearized pVA891 (Fig. 3, lane A) and the smal- 
ler one to pVA1-EcoRI-B (Fig. 3, laneB). 
EcoRl + Hindlll double digestion of pVA961 
yielded six fragments. (Fig. 3, lane F). The four 
smallest fragments corresponded to the EcoRl- 
Hindlll and Hindlll fragments of pVA1 (Fig. 3, 
lane E) that are known to comprise the EcoRI-B 
fragment of pVA 1 (see pVA 1 map in Macrina et ai., 
1980b). The two largest EcoRI-Hindlll fragments of 
pVA961 con'esponded to the pVA891 components 
(Fig. 3, lane D). The largest EcoRI-Hindlll fragment 
of pVA961 co-migrated with the largest EcoRl- 
Hindlll of pVAI (Fig. 3, lane E). However, the 
pVA961 fragment contained unique Pvull and Clal 
sites that establish its origin as pVA891 (not shown). 
Two lines of genetic evidence support our con- 
clusions regarding the structure of pVA961. First, 
this plasmid displayed thermosensitive replication in 
S. sanguis (Table I, lines 6 and 7, columns 5 and 6) 
consistent with the pVAl-phenotype. Second, 
pVA961 could be transformed successfully into 
E. coil V850, where it replicated stably and expressed 
Em ~ and Cm '. These results were consistent with 
pVA961 being an insertionally inactivated pVA891 
derivative. We conclude that the EcoRI-B fragment 
of pVAI contains an origin of replication. This 
observation also has been made by D. LeBlanc 
and L. Lee (personal communication). 
DISCUSSION 
In addition to affording a tool to isolate and study 
the nature of streptococcal plasmid replicators, 
pVA891 should be employable as a vehicle for 
mapping cloned S. sanguis genes, using the methodo- 
logy developed by Haldenwang etal. (1980) in 
Bacillus subtilis. Specifically, streptococcal genes 
cloned into pVA891 in E. coil, which might be identi- 
fied phenotypicaily or immunologically, could be 
introduced into S. sanguis, where the recombinant 
plasmid would be expected to integrate into the 
chromosome via a homologous pairing and a 
Campbell-like recombination event. The net result 
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would be the genomic incorporation of the pVA891 
replicon in toto, which would be monitored by stable 
Em ~. This directly selectable gene would now be 
linked to the gene of interest, which would have been 
duplicated following the integration event (see 
Halden,~Jang et al., 1980). This would afford several 
genetic options, including linkage analysis and gene 
inactivation (if the cloned sequence was defective). 
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